$AcelRx Ph_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":309210,"tweetId":"309210","gmtCreate":1539904960429,"gmtModify":1704778035260,"author":{"id":3473226850622810,"authorId":3473226850622810,"authorIdStr":"3473226850622810","name":"美股哥哥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$AcelRx Pharmaceuticals(ACRX)$ 拟死捏它一年，有信心收益300%以上，以此贴为记！</p></body></html>","htmlText":"<html><head></head><body><p>$AcelRx Pharmaceuticals(ACRX)$ 拟死捏它一年，有信心收益300%以上，以此贴为记！</p></body></html>","text":"$AcelRx Pharmaceuticals(ACRX)$ 拟死捏它一年，有信心收益300%以上，以此贴为记！","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/309210","repostId":0,"isVote":1,"tweetType":1,"viewCount":1344,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ACRX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":72,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":1087757,"gmtCreate":1539918294261,"gmtModify":1539918294261,"authorId":3470005502411851,"author":{"id":3470005502411851,"authorId":3470005502411851,"name":"路人丙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":309210,"type":1,"supId":0,"prevId":0,"content":"路过见证","text":"路过见证","html":"路过见证","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

评论（1）

热议股票